Iovance Biotherapeutics Inc (NASDAQ: IOVA) Hogging The Spotlight Today
The Vanguard Group, Inc. recently announced the acquisition of new stake in Iovance Biotherapeutics Inc (NASDAQ:IOVA). The institutional investor has increased its shareholding in the Healthcare company by 8.48% to 21.74 million shares with purchase of 1.7 million shares. This fresh investment now brings its stake to 8.49% valued currently at $131.96 million. In addition, […]
